Satoshi Suzuki

9PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersQuery processing and optimisationLiquid biopsiesMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 30, 2021
Preoperative neutrophil-to-lymphocyte ratio predicts the prognosis of esophageal squamous cell cancer patients undergoing minimally invasive esophagectomy after neoadjuvant chemotherapy.

Takashi Kato, Taro Oshikiri, Hironobu Goto

|Aug 02, 2021
Impact of chronic kidney disease stage on morbidity after gastrectomy for gastric cancer.

Satoshi Suzuki, Shingo Kanaji, Naoki Urakawa

|Apr 03, 2021
Surgically treated gastric cancer in Japan: 2011 annual report of the national clinical database gastric cancer registry.

Satoshi Suzuki, Arata Takahashi, Takashi Ishikawa

|Apr 26, 2020
Feasibility of laparoscopic endoscopic cooperative surgery for non-ampullary superficial duodenal neoplasms: Single-arm confirmatory trial.

Shingo Kanaji, Yoshinori Morita, Yuta Yamazaki

|Mar 30, 2019
Current status of minimally invasive esophagectomy for esophageal cancer: Is it truly less invasive?

Taro Oshikiri, Gosuke Takiguchi, Susumu Miura

|Jan 31, 2019
Recent advances of neoadjuvant chemoradiotherapy in rectal cancer: Future treatment perspectives.

Kimihiro Yamashita, Takeru Matsuda, Hiroshi Hasegawa

Pageof 2

Frequent Collaborators

6 joint publications

Shingo Kanaji

5 joint publications

Yoshihiro Kakeji

4 joint publications

Takeru Matsuda

4 joint publications

Taro Oshikiri